Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
UBS
Covington
Cipla
Daiichi Sankyo

Generated: April 23, 2019

DrugPatentWatch Database Preview

Details for Patent: 4,612,008

« Back to Dashboard

Summary for Patent: 4,612,008
Title: Osmotic device with dual thermodynamic activity
Abstract:An osmotic system is disclosed comprising a wall formed in at least a part of a semipermeable material that surrounds a compartment. The compartment contains a first osmotic composition comprising a beneficial agent, and a second and different osmotic composition. A passageway in the wall connects the first composition with the exterior of the system.
Inventor(s): Wong; Patrick S. L. (Hayward, CA), Barclay; Brian (Sunnyvale, CA), Deters; Joseph C. (Mt. View, CA), Theeuwes; Felix (Los Altos, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:06/685,092
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,612,008
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 4,612,008
Patent Claim Types:
see list of patent claims
Delivery; Device; Composition; Formulation;

Drugs Protected by US Patent 4,612,008

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 4,612,008

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 394944 ➤ Try a Free Trial
Austria 397180 ➤ Try a Free Trial
Austria A150789 ➤ Try a Free Trial
Austria A88084 ➤ Try a Free Trial
Australia 2251183 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Chubb
Federal Trade Commission
Citi
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.